ARVN Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 birž. 2024 @ 16:30):
Our systems believe the stock currently is overvalued by 0.46% compare to its pairs and should correct downwards.

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins...

Stats
Šios dienos apimtis	5 925
Vidutinė apimtis	715 865
Rinkos kapitalizacija	1.70B
EPS	$-0.970 ( Q1 \| 2024-05-07 )
Kita pelno data	( $0 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.10 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0370 (0.15%)

AADI 0.00%

ABCL 0.65%

ABCM 0.04%

ABEO -0.44%

ABIO 2.17%

ABOS -0.40%

ABSI 0.55%

ABUS 0.33%

ABVX -0.22%

ACAD 0.54%

ACER -17.95%

ACET 0.00%

ACGN 1.29%

ACHL -2.44%

ACHV 1.63%

ACIU 0.00%

ACLX 0.28%

ACRV 0.73%

ACST 0.62%

ACXP 1.68%

ADAG -5.64%

ADAP 0.33%

ADGI 0.87%

ADIL 1.57%

ADMA 0.29%

ADPT -0.96%

ADTX -1.27%

ADVM -0.55%

ADXN -6.11%

AEON 11.51%

AEZS -5.44%

AFMD -0.59%

AGEN -1.89%

AGIO 0.56%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 53.45%

AKBA -0.95%

AKRO 0.26%

AKTX -2.70%

AKUS 0.00%

ALBO 0.00%

ALDX 0.96%

ALEC 0.44%

ALGS -0.25%

ALKS 0.60%

ALLK -0.85%

ALLO -0.43%

ALLR -2.32%

ALNA 3.16%

ALNY -0.01%

ALPN 0.00%

ALPX 0.00%

ALRN -0.31%

ALT -0.76%

ALVR 0.60%

ALXN 0.00%

ALXO -1.49%

ALZN 0.00%

AMRN -2.37%

AMTI -3.13%

ANAB -0.94%

ANEB -5.58%

ANGN 0.00%

ANIX -1.14%

ANL 0.61%

ANNX -0.56%

ANPC -3.15%

APGE 0.36%

APGN 8.48%

APGNW 30.65%

APLM 10.18%

APLS 0.81%

APLT 0.21%

APM 1.33%

APOP 0.38%

APRE 2.44%

APTO 0.68%

APTX 3.17%

APVO -0.02%

ARAV -13.39%

ARCT -0.44%

ARDS 20.48%

ARDX 0.32%

ARGX 0.19%

ARNA 0.00%

ARPO -0.90%

ARQT -1.01%

ARTL -4.55%

ARTLW 9.80%

ARVN -0.60%

ARWR 0.00%

ASLN 2.75%

ASMB -0.86%

ASND 0.41%

ATAI 0.75%

ATHA -0.38%

ATHE -1.61%

ATHX -33.50%

ATNF -4.37%

ATOS 3.52%

ATRA -2.26%

ATXI -1.66%

ATXS 0.45%

AUPH -0.72%

AURA 0.68%

AUTL -0.23%

AVBP -0.27%

AVEO 0.00%

AVIR -0.28%

AVRO -2.05%

AVTE -4.84%

AVTX 4.15%

AVXL -0.13%

AXLA 0.00%

AXSM 0.07%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.40%

BCAB 1.92%

BCDA -0.30%

BCDAW -33.33%

BCEL -1.32%

BCLI -0.05%

BCRX -0.40%

BCTX -0.68%

BCTXW 0.00%

BCYC 0.00%

BDRX 1.05%

BDTX -0.55%

BEAM -0.12%

BFRA -2.91%

BGNE -0.62%

BIOR 0.03%

BIVI 1.73%

BLCM -6.68%

BLI -5.88%

BLPH -0.79%

BLRX 2.36%

BLTE -0.72%

BLU 0.03%

BLUE -0.61%

BMEA -0.57%

BMRN 0.19%

BNOX 10.76%

BNTC 2.46%

BNTX -0.03%

BOLD 0.49%

BOLT -0.50%

BPMC 0.55%

BPTH 1.26%

BPTS -13.47%

BRNS 2.96%

BRTX -9.90%

BTAI 0.75%

BTTX -7.50%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 0.00%

CABA -2.22%

CADL -0.83%

CALA 60.00%

CALC -1.62%

CALT -0.64%

CAPR -0.60%

CARA 2.12%

CARM 0.97%

CASI -2.41%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 2.44%

CCCC -1.09%

CCXI 0.00%

CDAK 0.00%

CDIO -3.01%

CDIOW 0.00%

CDMO -0.40%

CDMOP 0.04%

CDT -6.11%

CDTTW 294.32%

CDTX -0.08%

CDXC -1.19%

CDXS -1.49%

CELC 1.03%

CELU 7.05%

CELUW -9.52%

CERC -1.68%

CERE 0.41%

CERO -4.29%

CEROW -44.78%

CFRX -27.95%

CGEM -1.58%

CGEN -1.02%

CGON 0.00%

CGTX 1.39%

CHMA -6.00%

CHRS -0.61%

CINC 0.00%

CING 4.48%

CINGW -48.24%

CKPT -0.49%

CLBS -16.75%

CLDX 2.89%

CLGN 0.30%

CLLS -6.54%

CLNN 6.88%

CLNNW -41.25%

CLRB 0.67%

CLSD 0.86%

CLSN -0.68%

CLVS 0.00%

CMMB 10.18%

CMND 1.82%

CMPI 0.00%

CMPX 0.00%

CMRA 0.40%

CMRAW 33.33%

CMRX 1.11%

CNCE 0.00%

CNSP -1.73%

CNST 0.00%

CNTA 0.31%

CNTB 3.13%

CNTX -1.03%

COCP 0.42%

COEPW -0.66%

COGT -0.11%

CORT 0.10%

COYA 2.22%

CPRX 0.00%

CRBP -2.67%

CRBU 0.57%

CRDF -0.75%

CRGX 0.00%

CRIS 0.73%

CRNX -0.16%

CRSP 0.62%

CRTX 2.63%

CRVO -1.89%

CRVS 0.00%

CSBR 1.19%

CTCX -8.04%

CTIC 0.06%

CTMX 3.65%

CTNM -2.94%

CTXR -1.01%

CUE -0.75%

CVAC 0.86%

CVKD 1.37%

CWBR -2.55%

CYAD -12.96%

CYCC -2.45%

CYCCP -1.79%

CYCN 6.00%

CYT -2.27%

CYTK -0.13%

CYTO -3.23%

DARE 1.19%

DAWN 0.42%

DBTX -0.81%

DBVT 1.01%

DFFN 10.28%

DICE 0.06%

DMAC -0.42%

DNLI 1.12%

DNTH 0.04%

DOMH 1.99%

DRMA 0.00%

DRMAW 0.00%

DRNA 0.00%

DRTS -1.32%

DRTSW 1.01%

DRUG 0.00%

DSGN 0.00%

DTIL -1.19%

DYAI -5.29%

EARS -1.77%

EDIT 4.31%

EDSA 1.04%

EFTR -3.13%

EFTRW -0.26%

EIGR 0.00%

ELAB -2.87%

ELDN 0.71%

ELEV -0.84%

ELOX -12.50%

ELTX -2.33%

ELVN -0.65%

ELYM 0.52%

ENGN -3.89%

ENGNW -5.29%

ENLV 1.44%

ENOB 1.79%

ENSC 0.88%

ENTA -0.75%

ENTO 0.48%

ENTX 1.45%

ENVB 0.94%

EPIX 0.00%

EPRX -0.19%

EPZM 0.00%

EQ 1.40%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.50%

ERNA 4.79%

ERYP 1.30%

ESLA 1.14%

ESLAW -9.25%

ETNB -0.23%

ETON 1.19%

ETTX 0.00%

EVAX 4.45%

EVGN -2.55%

EVLO 50.00%

EWTX -0.58%

EXAI -0.20%

EXEL -0.30%

EYEG -0.43%

EYEN -0.33%

EYPT 0.00%

FATE 0.42%

FBIO 0.53%

FBIOP 1.09%

FBLG -5.34%

FBRX -7.46%

FDMT -0.67%

FENC 0.74%

FGEN 0.47%

FHTX 9.52%

FIXX 0.77%

FMTX 0.00%

FNCH -6.25%

FOLD 0.30%

FREQ 4.76%

FRLN 0.15%

FRTX -0.54%

FSTX 0.00%

FTRE 0.58%

FULC 0.00%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 3.20%

GANX -0.76%

GBIO 1.37%

GBT 0.01%

GDTC -7.21%

GERN -0.96%

GHRS 3.42%

GLMD -3.30%

GLPG 0.93%

GLSI -1.83%

GLTO 0.00%

GLUE 0.00%

GLYC 2.57%

GMAB 1.09%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT 0.97%

GNLX 0.00%

GNPX 1.84%

GNTA 0.00%

GOSS 11.54%

GOVX 20.09%

GOVXW -24.72%

GPCR 0.94%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -1.42%

GRTX -4.26%

GTHX 0.75%

GUTS 0.28%

GXGXW 41.67%

GYRE 0.17%

HALO 0.66%

HARP 0.09%

HCWB -9.73%

HEPA -6.36%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 0.56%

HOTH -3.73%

HOWL -1.27%

HRMY 0.00%

HRTX 1.40%

HSTO 62.16%

HUMA -0.32%

HUMAW -5.97%

IBRX -0.34%

ICCC 2.84%

ICPT 0.21%

ICU -0.26%

ICUCW -10.39%

ICVX -0.91%

IDRA -23.04%

IDYA -0.13%

IFRX -3.21%

IGMS 0.14%

IKNA 1.15%

IKT 8.90%

IMAB -1.10%

IMCR -0.71%

IMGN 0.02%

IMGO 0.00%

IMMP -1.47%

IMMX -0.49%

IMNM 0.00%

IMNN -0.90%

IMPL -27.27%

IMRA 15.96%

IMRN -2.78%

IMRX 0.32%

IMTX -0.85%

IMTXW -2.70%

IMUX 1.75%

IMV 0.00%

IMVT -1.34%

INAB -0.02%

INBX -0.35%

INCY 0.02%

INDP -3.03%

INFI -52.38%

INKT -0.39%

INM 1.46%

INMB -0.60%

INO 0.00%

INSM -0.05%

INTS 0.84%

INVA 1.55%

INZY 0.44%

IOBT -6.11%

IONS -0.37%

IOVA -0.25%

IPA 0.00%

IPHA -10.64%

IPSC 0.95%

IRON -0.48%

ISEE 0.38%

ITOS -0.84%

ITRM -2.61%

IVA 2.64%

IVVD 0.00%

JAGX -0.26%

JANX 0.17%

JAZZ 0.06%

JNCE 0.00%

JSPR -0.08%

JSPRW 2.33%

JUNS 0.00%

JUNSW 0%

KA -5.56%

KALV -0.42%

KDNY 0.22%

KMPH -0.34%

KNSA -0.05%

KNTE -0.38%

KOD 0.00%

KPRX 8.51%

KPTI -0.28%

KRBP 4.17%

KRON 0.00%

KROS -1.57%

KRRO -0.63%

KRTX 0.03%

KRYS 0.24%

KTRA 9.15%

KTTA -2.85%

KTTAW 8.62%

KURA 1.02%

KYMR -0.38%

KYTX -0.25%

KZIA 8.44%

KZR 0.65%

LABP 0.57%

LBPH -0.97%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.19%

LENZ -1.30%

LEXX -0.68%

LEXXW -9.42%

LGND -0.46%

LGNDV 0.00%

LGVN -12.69%

LIAN 0.00%

LIFE 2.70%

LIPO -1.23%

LIXT 0.40%

LIXTW 27.74%

LJPC -0.32%

LMNL 0.12%

LOGC -0.72%

LPCN 2.99%

LPTX -1.93%

LQDA -0.23%

LRMR 1.13%

LSTA -4.97%

LTRN -2.24%

LUMO 0.00%

LVTX -1.42%

LXEO -1.05%

LXRX 0.87%

LYEL 3.12%

LYRA -1.26%

MACK 0.00%

MBIO 35.33%

MBRX -4.83%

MCRB -0.58%

MDGL 0.06%

MDNA -13.16%

MDWD 1.00%

MDXG 0.15%

MEIP 1.41%

MESO 2.12%

MGNX -1.15%

MGTA -7.74%

MGTX -1.14%

MGX 2.85%

MIRM 1.12%

MIRO 0.59%

MIST 2.96%

MITO 0.00%

MLEC -4.55%

MLECW 9.20%

MLND -5.36%

MLTX 0.09%

MLYS -0.66%

MNKD 0.21%

MNMD 0.53%

MNOV 0.00%

MNPR 3.39%

MOLN 2.88%

MOR -0.54%

MORF 1.36%

MREO 0.00%

MRKR -4.76%

MRNA -0.72%

MRNS 2.07%

MRSN 0.00%

MRTX -0.17%

MRUS -1.24%

MRVI 0.28%

MTCR -1.29%

MTEM 1.54%

MTP -18.50%

MURA -0.30%

MYMD -0.91%

NAMS -0.39%

NAMSW -7.61%

NAUT 1.17%

NBRV 0.71%

NBSE -1.56%

NBTX -6.05%

NCNA -1.64%

NERV 0.00%

NEXI -1.40%

NGM -1.28%

NGNE -3.95%

NKGN 0.78%

NKGNW 39.76%

NKTR -0.85%

NKTX -1.23%

NLSP 159.36%

NLSPW 8.38%

NMRA 0.53%

NMTR -42.97%

NOVN -24.84%

NRBO 0.45%

NRIX 4.90%

NRSN -4.95%

NRSNW 6.50%

NRXP 0.99%

NRXPW -15.65%

NRXS -6.06%

NTBL 2.92%

NTEC -12.45%

NTHI 0%

NTLA 0.00%

NTRBW -6.25%

NUVL 0.43%

NVAX -0.71%

NVCT 1.18%

NVIV -34.28%

NXTC 0.70%

NYMX -0.05%

OABI -0.47%

OABIW 13.46%

OBIO -0.87%

OBSV 0.00%

OCEA -3.21%

OCGN 2.99%

OCS -1.09%

OCUL -1.45%

OCUP 0.59%

ODT -4.27%

OKYO 0.00%

OLMA -0.47%

OMER 0.87%

OMGA 8.60%

ONCO 18.53%

ONCR -3.08%

ONCS 31.87%

ONCT -0.12%

ONCY -0.99%

ONTX -0.47%

ONVO -2.35%

OPNT 0.00%

OPT 0.80%

ORGS -1.72%

ORIC -0.13%

ORMP 0.00%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 0.26%

OVID -5.04%

OYST 0.00%

PALI 0.86%

PASG -0.99%

PBLA 9.76%

PBM -0.02%

PBYI -0.63%

PCSA 5.71%

PCVX 0.31%

PDSB 0.19%

PEPG 0.70%

PGEN 0.63%

PHAR 2.17%

PHAS 0.00%

PHAT -0.60%

PHIO 6.80%

PHIOW 36.47%

PHVS -0.53%

PHXM -5.20%

PIRS -5.64%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.27%

PLUR 0.00%

PMN 0.00%

PMVP 0.00%

PNT 0.16%

PPBT 2.78%

PRAX 6.05%

PRDS 0.93%

PRLD 0.77%

PROG -3.47%

PROK 0.34%

PRQR -5.29%

PRTA 0.34%

PRTC -0.72%

PRTG 6.52%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 0.00%

PSTX 1.81%

PTCT 0.06%

PTE -0.82%

PTGX 0.03%

PTIXW 2.50%

PULM 3.72%

PXMD -1.92%

PYPD -0.36%

PYXS 1.09%

QLGN 17.86%

QNCX -1.41%

QNRX 3.04%

QSI 0.75%

QSIAW 0.00%

QTTB 0.00%

QURE -0.75%

RAIN -1.63%

RANI 0.00%

RAPT -0.30%

RARE -0.28%

RCKT 0.19%

REGN 0.11%

RENB 0.00%

REPL -0.13%

RETA 0.02%

REUN -0.89%

REVB 5.26%

REVBU 3.46%

REVBW 25.20%

RGLS 0.42%

RGNX 1.12%

RIGL 2.54%

RLAY 0.21%

RLMD 0.00%

RLYB 0.00%

RNA -1.52%

RNAC -1.07%

RNAZ 0.00%

RNXT 0.75%

ROIV 0.28%

ROIVW 4.56%

RPHM -0.60%

RPRX 0.04%

RPTX 1.58%

RUBY 2.70%

RVLP -32.05%

RVMD -0.16%

RVMDW -23.93%

RVNC 0.36%

RVPH 0.00%

RVPHW 11.54%

RXDX 0.09%

RXRX -0.64%

RYTM 0.46%

RYZB 0.02%

RZLT 0.00%

SABS -2.75%

SABSW -32.14%

SAGE 0.71%

SANA -0.17%

SAVA -0.80%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -10.91%

SCPH 0.00%

SCPS 0.00%

SEEL -1.16%

SEER -0.58%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.00%

SGMT -0.47%

SGTX -2.56%

SIOX 22.63%

SLDB -0.40%

SLGL -2.22%

SLN -1.55%

SLNO 0.38%

SLRX 5.16%

SLS -3.19%

SMMT 0.76%

SNDX 0.13%

SNGX 0.79%

SNPX -3.97%

SONN -4.75%

SPPI -0.49%

SPRB 0.49%

SPRC -2.02%

SPRO 3.13%

SRNE 20.00%

SRPT 0.55%

SRRA 0.00%

SRRK -0.34%

SRZN -1.70%

STAB 0.00%

STOK -0.26%

STRO 0.63%

STSA 0.00%

STTK 0.40%

SURF -0.93%

SVRA -0.52%

SWTX -0.75%

SYBX -0.63%

SYRS -1.93%

TALS -0.73%

TARA -0.78%

TARS 1.72%

TBPH -0.12%

TCBP 1.78%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -3.13%

TCRX -1.21%

TECH 0.07%

TENX -3.43%

TERN 0.00%

TFFP -2.05%

TGTX 0.29%

THRX 0.12%

TIL -2.06%

TLC 0.00%

TLSA 0.66%

TNGX 0.59%

TNXP 0.89%

TNYA 0.00%

TPST 0.34%

TRDA -3.61%

TRVI -0.18%

TRVN -1.88%

TSHA -5.33%

TSVT -0.49%

TTNP 1.45%

TVTX -0.27%

TYRA -0.39%

UBX 0.72%

UNCY -0.11%

URGN -7.71%

UTHR 0.08%

VACC 11.36%

VALN -2.51%

VAXX -0.11%

VBIV 1.15%

VBLT -8.77%

VCEL 0.50%

VCNX -1.54%

VCYT -0.09%

VERA -0.08%

VERU 0.50%

VERV -1.33%

VIGL -2.75%

VINC 1.05%

VIR -0.87%

VIRI -5.41%

VIRX -6.84%

VKTX -0.02%

VLON -13.04%

VNDA 0.63%

VOR 0.85%

VRCA 0.00%

VRDN -0.74%

VRNA 1.48%

VRPX -11.90%

VRTX -0.06%

VSTM 0.29%

VTGN 1.46%

VTVT -0.10%

VTYX -0.36%

VXRT 5.86%

VYGR 0.10%

VYNE 2.16%

VYNT 7.78%

WINT 5.59%

WVE -0.67%

XBIO 6.75%

XBIT -0.66%

XCUR -0.65%

XENE 0.30%

XERS 0.00%

XFOR -0.54%

XLO 0.00%

XLRN 0.00%

XNCR -0.41%

XOMA 0.00%

XOMAO -0.56%

XOMAP -0.14%

XRTX 2.97%

YMAB 0.26%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.20%

ZNTL -25.39%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-29	Bain Linda	Buy	5 899	Common Stock
2024-05-29	Bain Linda	Buy	9 070	Stock Option (right to buy)
2024-05-29	Cunningham Everett	Buy	5 899	Common Stock
2024-05-29	Cunningham Everett	Buy	9 070	Stock Option (right to buy)
2024-05-29	Kennedy Edward Moore Jr.	Buy	5 899	Common Stock

INSIDER POWER
50.35
Last 95 transactions
Buy: 1 604 823 \| Sell: 436 779

Koreliacija (AI algo v.1.1b): Overvalued: 0.46% $24.82 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.17 (neutral)

Trumpas: 0.37 (neutral)

Signal:(69.654) Neutral

Arvinas Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
OZEM	1
DOMO	0.928
WSC	0.928
RGEN	0.912
BMEA	0.909
WRAP	0.9
BKHAU	0.898
BRZE	0.894
CRBU	0.889
IPA	0.888

10 Labiausiai neigiamai susiję koreliacijos
ARBFX	-0.957
FSCHX	-0.936
CISS	-0.92
AEDFX	-0.916
NA	-0.915
FDFF	-0.904
NVNI	-0.901
KCOPX	-0.901
INDH	-0.899
BUFMX	-0.896

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Arvinas Inc Koreliacija - Valiuta/Žaliavos

-0.41
( neutral )

-0.35
( neutral )

0.00
( neutral )

-0.28
( neutral )

0.00
( neutral )

0.53
( weak )

Arvinas Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$78.50M
Bruto pelnas:	$71.80M (91.46 %)
EPS:	$-6.62

FY	2023
Pajamos:	$78.50M
Bruto pelnas:	$71.80M (91.46 %)
EPS:	$-6.62

FY	2022
Pajamos:	$131.40M
Bruto pelnas:	$123.20M (93.76 %)
EPS:	$-5.11

FY	2021
Pajamos:	$46.00M
Bruto pelnas:	$46.00M (100.00 %)
EPS:	$-3.82

Financial Reports:

No articles found.

Arvinas Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Arvinas Inc

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.